PCOS: Understanding Polycystic Ovary Syndrome, Treatment, and Long-Term Health

By VitalPath Editorial | June 26, 2026 | Sexual Health Meta Description: Polycystic Ovary Syndrome affects 8–13% of women and is the leading cause of infertility. Learn PCOS symptoms, diagnostic criteria, treatment from lifestyle to medication, and the long-term health implications beyond reproduction.

---

Introduction: More Than a Reproductive Disorder

Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting 8–13% of women worldwide. Despite its name, PCOS is not primarily an ovarian condition—it's a complex metabolic and hormonal disorder with reproductive, metabolic, cardiovascular, and psychological implications.

⏱ 6 min read

Up to 70% of women with PCOS remain undiagnosed. Many are told their irregular periods are "just how their body works," their weight gain is a personal failing, and their acne or hair growth is a cosmetic issue. The underlying metabolic dysfunction—insulin resistance—often goes unrecognized and untreated for years.

PCOS affects fertility, but it's much more than a fertility problem. Understanding and managing PCOS is important for every aspect of health across the lifespan.

Internal link: PCOS often affects libido and sexual function—read Sexual Desire: The Science of Libido.

---

What Is PCOS?

PCOS is characterized by a combination of: 1. Androgen excess: Elevated male hormones (testosterone, androstenedione, DHEA-S) 2. Ovulatory dysfunction: Irregular or absent ovulation → irregular or absent periods 3. Polycystic ovarian morphology: Multiple small follicles visible on ultrasound (not actually "cysts" but immature follicles that failed to develop)

The Central Role of Insulin Resistance

Insulin resistance is the core metabolic abnormality in PCOS, present in 65–80% of women with the condition, independent of body weight. Here's how it drives PCOS:

1. Insulin resistance → compensatory hyperinsulinemia (high insulin levels) 2. High insulin stimulates the ovaries to produce excess androgens (testosterone) 3. High insulin reduces SHBG (sex hormone binding globulin) production in the liver → more free, active testosterone 4. Excess androgens disrupt normal follicular development → anovulation 5. Anovulation → absent progesterone → unopposed estrogen → endometrial overgrowth

This is why treating insulin resistance is the cornerstone of PCOS management—not just for metabolic health, but for reproductive and hormonal health as well.

---

Symptoms and Signs

Reproductive

Irregular, infrequent, or absent periods (<8 periods="periods" per="per" year="year">

Heavy menstrual bleeding (when periods do occur, due to endometrial buildup)

Infertility (PCOS is the leading cause of anovulatory infertility)

Recurrent miscarriage (3x higher risk)

Androgen Excess

Hirsutism (male-pattern hair growth): Face, chin, chest, abdomen, back

Acne (particularly along jawline and lower face, often persistent into adulthood)

Male-pattern hair loss (androgenic alopecia)

Oily skin

Metabolic

Weight gain and difficulty losing weight (particularly abdominal/visceral pattern)

Insulin resistance and prediabetes (PCOS women have 4x higher type 2 diabetes risk)

Dyslipidemia (high triglycerides, low HDL)

Acanthosis nigricans (dark, velvety skin patches on neck, armpits, groin—a sign of insulin resistance)

Skin tags (acrochordons)

Psychological

Depression and anxiety (significantly higher rates than women without PCOS)

Eating disorders (higher rates, possibly related to body image distress and weight cycling)

Reduced quality of life

---

Diagnosis

Rotterdam Criteria (Most Widely Used)

PCOS is diagnosed when 2 of 3 criteria are met (after excluding other causes):

1. Oligo-ovulation or anovulation (irregular or absent periods) 2. Clinical or biochemical hyperandrogenism (hirsutism, acne, hair loss, or elevated testosterone on blood work) 3. Polycystic ovaries on ultrasound (≥20 follicles per ovary or ovarian volume >10 mL)

Excluding Other Conditions

Thyroid dysfunction

Hyperprolactinemia

Non-classic congenital adrenal hyperplasia

Androgen-secreting tumors

Cushing's syndrome

Hypothalamic amenorrhea (distinguished by low LH, normal androgens)

---

Treatment: A Multi-System Approach

Lifestyle: The Foundation

Weight management: Even 5–10% weight loss significantly improves insulin sensitivity, restores ovulation, reduces androgens, and improves fertility in overweight women with PCOS. However, weight loss is more difficult with PCOS due to insulin resistance—this is biological, not a failure of willpower. Dietary strategies:

Lower glycemic index/load: Reduces postprandial insulin spikes. Emphasize whole grains, legumes, non-starchy vegetables; limit refined carbohydrates and added sugars.

Adequate protein: 25–30% of calories improves satiety and stabilizes blood glucose.

Healthy fats: Monounsaturated and omega-3 fats improve lipid profiles and reduce inflammation.

Inositol: Myo-inositol (2–4g/day) improves insulin sensitivity and ovulation in PCOS. D-chiro-inositol at lower doses may augment effects. 40:1 myo:DCI ratio mimics physiological ratios.

Mediterranean diet: Consistent benefits for metabolic parameters.

Exercise: Both aerobic and resistance training improve insulin sensitivity. Even without weight loss, exercise improves metabolic parameters. Aim for 150+ minutes moderate activity + 2 strength sessions weekly. Sleep: Sleep deprivation worsens insulin resistance. Women with PCOS have higher rates of obstructive sleep apnea (independent of BMI). Screen and treat.

Medication

Hormonal Contraceptives: First-line for menstrual regulation and androgen suppression:

Combined OCPs suppress ovarian androgen production and increase SHBG

Anti-androgenic progestins (drospirenone, cyproterone) provide additional benefit for hirsutism and acne

Cyclic or continuous use regulates bleeding and protects the endometrium

Anti-Androgens:

Spironolactone: Blocks androgen receptors. Effective for hirsutism and acne. Requires contraception (teratogenic—feminizes male fetuses). Dose: 50–200mg/day.

Finasteride: 5-alpha reductase inhibitor. Less studied in PCOS but effective for hirsutism. Also requires contraception.

Insulin Sensitizers:

Metformin: Improves insulin sensitivity, modestly reduces androgens, and may restore ovulation in some women. Less effective than lifestyle intervention alone. GI side effects common (start low, go slow). Dose: 1,500–2,000mg/day.

GLP-1 agonists (liraglutide, semaglutide): Significant weight loss, improved insulin sensitivity, and ovulation restoration. Increasingly used in PCOS, particularly with obesity. Expensive.

Ovulation Induction (for fertility):

Letrozole: Aromatase inhibitor. Now first-line over clomiphene for PCOS. Higher live birth rates in RCTs. Dose: 2.5–7.5mg/day for 5 days.

Clomiphene citrate: Traditional first-line. Estrogen receptor modulator. Lower live birth rates than letrozole in PCOS; higher multiple pregnancy rates.

Gonadotropins: Injectable FSH. Reserved for letrozole/clomiphene failures due to cost, monitoring requirements, and higher multiple pregnancy risk.

---

Long-Term Health Risks

PCOS extends far beyond reproduction:

Type 2 diabetes: 4x increased risk; onset 10–20 years earlier than women without PCOS

Cardiovascular disease: Adverse lipid profiles, hypertension, increased carotid intima-media thickness. Long-term cardiovascular event data limited but concerning.

Endometrial hyperplasia and cancer: Chronic anovulation → unopposed estrogen → endometrial proliferation → 3x increased endometrial cancer risk. Regular withdrawal bleeds (at least 4/year) are essential for protection.

Obstructive sleep apnea: 5–10x increased risk, independent of BMI

Non-alcoholic fatty liver disease: Increased prevalence, driven by insulin resistance

Mood disorders: Higher lifetime rates of depression and anxiety

The takeaway: PCOS management is a lifelong endeavor, not just a fertility issue. Regular follow-up, metabolic monitoring, and cardiovascular risk reduction are essential.

---

---

🛒 Recommended Products for Sexual Health

As an Amazon Associate, we earn from qualifying purchases. This does not affect the price you pay or our editorial integrity.

🔍 Other Excellent Options

This article is for informational purposes only and does not constitute medical advice. PCOS diagnosis and management should be directed by a healthcare provider.

---

Related Articles:

Endometriosis: Diagnosis and Treatment Guide

Sexual Desire: The Science of Libido

Diabetes Prevention: Blood Sugar Control

Metabolic Syndrome: Reversal Guide

Communication and Intimacy: Building Connection

---

References: 1. Teede HJ, et al. "Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome." Human Reproduction, 2018. 2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. "Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome." Human Reproduction, 2004. 3. Legro RS, et al. "Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome." New England Journal of Medicine, 2014. 4. Moran LJ, et al. "Lifestyle changes in women with polycystic ovary syndrome." Cochrane Database of Systematic Reviews, 2011. 5. Azziz R, et al. "Polycystic ovary syndrome." Nature Reviews Disease Primers, 2016. Focus Keywords: PCOS symptoms, PCOS treatment, polycystic ovary syndrome, PCOS diet, PCOS and insulin resistance Slug: pcos-guide-symptoms-treatment Category: sexual-health